GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹752 Cr | ₹2,186 Cr | ₹-1,560 Cr | ₹1,587 Cr | ₹-177 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLAND PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹752 Cr |
| Mar2025 | ₹2,186 Cr |
| Mar2024 | ₹-1,560 Cr |
| Mar2023 | ₹1,587 Cr |
| Mar2022 | ₹-177 Cr |
How is Net Cash Inflow / Outflow of GLAND PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹752 Cr | -65.59 | |
| Mar2025 | ₹2,186 Cr | Positive | |
| Mar2024 | ₹-1,560 Cr | Negative | |
| Mar2023 | ₹1,587 Cr | Positive | |
| Mar2022 | ₹-177 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹50,735.0 Cr | 8.8% | 6.2% | 57.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 8.8% |
6.2% |
57.7% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses